Market Overview The gout therapeutics market was valued at USD 3.13 billion in 2024 and is projected to grow at a CAGR of 7.0% from 2025 to 2034, according to Polaris Market Research. Gout is a form of inflammatory arthritis caused by uric acid crystal deposition. The market covers pharmaceutical products and treatment approaches that manage and relieve symptoms, including urate-lowering...